We are live on
!
Find out more
TC
Trium Capital Portfolio holdings
AUM
$79.4M
Turnover
54.79%
1-Year Est. Return
36.67%
This Fund
S&P 500
This Quarter
Est. Return
-3.48%
1 Year Est. Return
+36.67%
3 Year Est. Return
+214.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$20.6M
(+14%)
Cap. Flow
+$19M
Cap. Flow
% of AUM
11.69%
Top 10 Holdings %
Top 10 Hldgs %
79.52%
Holding
80
New
17
Increased
25
Reduced
11
Closed
27
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Esperion Therapeutics
ESPR
|
+$31.2M |
| 2 |
AT&T
T
|
+$26.6M |
| 3 |
Alumis Inc
ALMS
|
+$4.63M |
| 4 |
Elme Communities
ELME
|
+$4.37M |
| 5 |
NextEra Energy
NEE
|
+$1.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STKL
SunOpta
STKL
|
+$9.32M |
| 2 |
Hologic
HOLX
|
+$8.51M |
| 3 |
OS
OneStream Inc
OS
|
+$6.55M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$6.15M |
| 5 |
Sapiens International
SPNS
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 36.07% |
| 2 | Healthcare | 29.44% |
| 3 | Industrials | 14.19% |
| 4 | Technology | 6.43% |
| 5 | Real Estate | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
AT&T
T
$162B
| $57.8M | 35.53% |
1,966,000
+1,073,000
| +120% | +$26.6M |
2026 Q1
1 quarter
|
|
|
2
DELISTED
Esperion Therapeutics
ESPR
| $35.3M | 21.69% |
+11,158,150
| New | +$31.2M |
2026 Q2
0 quarters
|
|
|
3
Alumis Inc
ALMS
$804M
| $11M | 6.76% |
390,268
+198,877
| +104% | +$4.63M |
2025 Q2
4 quarters
|
|
|
4
DELISTED
Sapiens International
SPNS
| $7.56M | 4.65% |
173,884
-122,499
| -41% | -$5.32M |
2026 Q1
1 quarter
|
|
|
5
Elme Communities
ELME
$156M
| $4.96M | 3.05% |
3,351,292
+2,157,674
| +181% | +$4.37M |
2026 Q1
1 quarter
|
|
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$816B
| $3.4M | 2.09% |
3,012,000
+2,027,400
| +206% | +$1.47B |
2024 Q2
8 quarters
|
|
7
Wabtec
WAB
$49B
| $3.36M | 2.07% |
12,454
+4,094
| +49% | +$1.08M |
2023 Q4
10 quarters
|
|
8
Linde
LIN
$231B
| $2.11M | 1.3% |
4,066
+630
| +18% | +$319K |
2023 Q3
11 quarters
|
|
9
Rockwell Automation
ROK
$48.1B
| $1.96M | 1.21% |
+3,966
| New | +$1.73M |
2026 Q2
0 quarters
|
|
10
Owens Corning
OC
$9.16B
| $1.93M | 1.19% |
12,134
-342
| -3% | -$41.6K |
2023 Q1
13 quarters
|
|
11
Ferguson
FERG
$44.8B
| $1.92M | 1.18% |
8,104
+1,778
| +28% | +$429K |
2026 Q1
1 quarter
|
|
12
nVent Electric
NVT
$23.6B
| $1.89M | 1.16% |
11,162
-4,696
| -30% | -$732K |
2024 Q1
9 quarters
|
|
13
Corteva
CTVA
$8.62B
| $1.88M | 1.15% |
22,162
+3,652
| +20% | +$293K |
2025 Q4
2 quarters
|
|
|
14
NextEra Energy
NEE
$166B
| $1.85M | 1.14% |
+21,124
| New | +$1.91M |
2026 Q2
0 quarters
|
|
15
Republic Services
RSG
$70.5B
| $1.83M | 1.13% |
8,596
-1,453
| -14% | -$304K |
2023 Q1
13 quarters
|
|
16
Darling Ingredients
DAR
$9.58B
| $1.76M | 1.08% |
32,136
+12,383
| +63% | +$739K |
2025 Q3
3 quarters
|
|
17
Waste Connections
WCN
$41.6B
| $1.73M | 1.07% |
+10,398
| New | +$1.65M |
2026 Q2
0 quarters
|
|
18
Essential Utilities
WTRG
$11.5B
| $1.71M | 1.05% |
44,644
+13,023
| +41% | +$497K |
2026 Q1
1 quarter
|
|
19
Public Service Enterprise Group
PEG
$35.5B
| $1.61M | 0.99% |
19,850
+205
| +1% | +$16.4K |
2025 Q4
2 quarters
|
|
20
Atrium Therapeutics
RNA
$137M
| $1.52M | 0.94% |
+113,278
| New | +$1.48M |
2026 Q2
0 quarters
|
|
21
Johnson Controls International
JCI
$90B
| $1.49M | 0.92% |
10,196
-1,489
| -13% | -$210K |
2026 Q1
1 quarter
|
|
22
MasTec
MTZ
$15.4B
| $1.4M | 0.86% |
3,366
+204
| +6% | +$78K |
2026 Q1
1 quarter
|
|
23
Zurn Elkay Water Solutions
ZWS
$7.8B
| $1.25M | 0.77% |
+24,678
| New | +$1.21M |
2026 Q2
0 quarters
|
|
24
QXO Inc
QXO
$11.4B
| $1.22M | 0.75% |
+70,478
| New | +$1.31M |
2026 Q2
0 quarters
|
|
25
Weyerhaeuser
WY
$14.1B
| $1.22M | 0.75% |
50,866
+11,443
| +29% | +$278K |
2024 Q2
8 quarters
|
|
Similar funds
WCM
AOCA
GMH
CAN
CMU
AC
LC
DCI
Trium Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Trium Capital held 80 positions worth $163M, up 14% from $142M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Trium Capital deployed $19M of net new capital in Q2 2026, opening 17 new positions and adding to 25 existing holdings. Its largest new stake was Esperion Therapeutics: 11,158,150 shares worth $35.3M.
By sector, the portfolio is most concentrated in Communication Services at 36% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Sapiens International, an estimated $5.32M trimmed.
- Trium Capital's largest Q2 2026 buy was Esperion Therapeutics: 11,158,150 shares worth $35.3M.
- Trium Capital added most to AT&T in Q2 2026, an estimated $26.6M increase.
- Trium Capital's biggest Q2 2026 reduction was Sapiens International, cutting an estimated $5.32M.
- Trium Capital fully exited SunOpta in Q2 2026, selling an estimated $9.32M.
- Trium Capital's ten largest holdings make up 80% of its $163M portfolio in Q2 2026.
- Trium Capital opened 17 new positions and closed 27 in Q2 2026.
- Trium Capital's portfolio value rose 14% quarter-over-quarter to $163M.
Based on Trium Capital's 13F filing for Q2 2026, filed 16 Jul 2026.